Killing human lymphoma and leukemia cancer cells and TCR-activated normal human cells by dopamine D1R agonists

Details for Australian Patent Application No. 2006278514 (hide)

International Classifications

Event Publications

3 April 2008 Assignment before Grant

Mineuet Therapeutics Ltd. The application has been assigned to Mia Levite Assignments before Grant, Section 113 2007

3 April 2008 PCT application entered the National Phase

PCT publication WO2007/019266 Priority application(s): WO2007/019266

7 August 2008 Amendment Made

The nature of the amendment is to amend the priority details from: 60/704,728 03 Aug 2005 US to: 60/757,687 11 Jan 2006 US and 60/704,729 03 Aug 2005 US 2006282930 The Regents of the University of California The nature of the amendment is: Amend the name of the co-inventor from Bakajin,Oligica to Bakagin, Olgica

5 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.